Blood prèssure levels in young students. Correlation between body mass and metabolic and hemodynamic factors;Niveles de presion arterial en jovenes estudiantes: Correlacion con la masa corporal, factures metabolicos y hemodinamicos

Medicina

Volumn 56, Issue 2, 1996, Pages 161-168

  De Lena, Susana M ^a   Echeverria, Raul F ^a   Escudero, Eduardo ^a   Gende, Oscar A ^a   Cingolani, Horacio E ^a,b  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; COMPARATIVE STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEMODYNAMICS; HUMAN; MALE; METABOLISM; PHYSIOLOGY; SEXUAL DEVELOPMENT; THROMBOCYTE; VASCULAR RESISTANCE;

ADULT; BLOOD GLUCOSE; BLOOD PLATELETS; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INSULIN; MALE; SEX CHARACTERISTICS; VASCULAR RESISTANCE;

EID: 0029684245     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Krieger DR, Lansberg L. Obesity and Hypertension, In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysioiogy, Diagnosis and Management. New York: Raven Press, 1995; 2367-88.
2. Elliot P. Observational studies of salt and blood pressure. Hypertension 1991; 17 (suppl 1): 13-8.
3. Messerli FH, Sundgaard-Rüse K, Reisin E, Dreslinski G, Dunn FH, Frolich E. Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med 1983; 74: 808-12.
4. Rowe JW, Young JB, Minaker KL, Stevens JP, and Landsberg L. Effect of Insulin and glucose infusions on sympathetic nervous system activity in normal men. Diabetes 1981; 30: 219-25.
5. The Fifth Report of the Joint National Committee on detection, evaluation and treatment of high blood pressure (JNC-V). Arch Int Med 1993; 153: 154-83.
6. Haffner S, Valdez R, Hazuda H, Mitchell B, Morales P, Stern M. Prospective analysis of the insulin-resistance syndrome (Syndrome X) Diabetes 1992; 41. 715-22.
7. Shan DJ, De Maria A, Kisslo J, Weymann AE. Recommendations regarding quantitation in M-mode echocardiography. Results of survey of echocardiography measurements. Circulation 1978; 57: 1072-83.
8. Teichholz LE, Kreulen TH, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echo-angiographic correlations. Circulation 1972; 46 (Suppl N): 75.
9. Finkielman S, Worcel M, Agrest A. Hemodynamic patterns in essential hypertension. Circulation 1965; 31: 356-68.
10. De Lena S, Rinaldi G, Almirón M, Gende O, Cingolani H. Consideraciones sobre la definición de hipertensión arterial a partir de un estudio de prevalencia en 1423 jóvenes. Medicina (Buenos Aires) 1992; 52: 119-30.
11. Voors AW, Webber LS, Frerichs RR, Berenson GS. Body height and body mass as determinants of basal blood pressure in children-the Bogalusa Heart Study. Am J Epidemiol 1977; 106: 101-8.
12. Havlik RJ, Hubert HB, Fabsitz RR, Feinleib M. Weight and hypertension. Ann Intern Med 1983; 98 (Part 2): 855-9.
13. Dyer AR, Elliot P, Shipley M. Body mass index versus height and weight in relation to blood pressure: findings for the 10.079 persons in the Intersalt Study. Am J Epidemiol 1990; 131: 589-96.
14. Intersatt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Br Med J 1988; 297: 319-28.
15. Law M, Frost C, Wald N. By how much does dietary salt reduction lower blood pressure? I- Analysis of observational data among populations. Br Med J 1991; 302-811-5.
16. Lund-Johansen P, Omvik P. Hemodynamtc patterns of untreated hypertensive disease. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Management. New York: Raven Press, 1995; 323-41.
17. Julius S, Conway I. Hemodynamic studies in patients with borderline blood pressure elevation. Circulation 1968; 38: 282-8.
18. 8 Julius S, Krause L, Schork N, Mejia AD, Jones KA, van de Ven C. Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens 1991; 9: 77-84
19. Reaven GM. Role of insulin resistance in human disease: Banting Lecture 1988. Diabetes 1988; 37: 1595-607.
20. Foster DW. Insulin resistance: a secret killer? N Engl J Med 1987; 320: 733-34.
21. Kaplan NM. The deadly quartet: upper body adiposity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 1989; 149: 1514-20.
22. Baron AD, Brechtel-Hook G, Johnson A, Hardin D. Skeletal muscle blood flow: A possible link between insulin resistance and blood pressure. Hypertension 1993; 21: 129-35.
23. Bonora E, Moghetti P, Zancanaro C, et al. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglicemic and hiperglicemic glucose clamp studies. J Clin Endocrinol Metab 1989; 68: 374-8.
24. Rosskopf D, Dusing R, Siffert W. Membrane sodium-proton exchange and primary hypertension. Hypertension 1993; 21: 607-17.
25. Canessa M, Adragna M, Solomon HS, Connolly TM, Tosteson DC. Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 1980; 302: 772-6.
26. Berk BC, Canessa M, Vallega G, Alexander RW. Agonist mediated changes in intracellular pH: role in vascular smooth muscle cell function. J Cardiovasc Pharmacol 1980; 12 (Suppl 5): s104-s14.
27. + secretion in the proximal tubule. Am J Physiol 1983; 245: 647-59.
28. + exchange and growth factor-induced cytosolic pH changes: role in cellular proliferation. Biochim Biophys Acta 1989; 988: 73-97.
29. Mannesmith RL, Aronson PS. The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological processes. Circ Res 1985; 56: 773-8.
30. Modan M, Halkin H, Lusky A, Segal P, Fuchs Z, Chetrit A. Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL and HLO levels. Arteriosclerosis 1988; 8: 227-36.
31. + exchange in vascular smooth muscle cells from WKY and SHR: effects of phorbol ester. Am J Physiol 1995; 268 (Cell Physiol 37): c14-c20.
32. + antiporter phenotype, abundance, and phosphorylation of immortalized lymphoblasts from humans with hypertension. Hypertension 1995; 25: 971-7.
33. Resnick LM, Gupta RK, Sosa RE, Corbett ML, Laragh JH. Intracellular pH in human and experimental hypertension. Proc Natl Acad Sci USA 1987; 84: 7663-7.
34. Astaire C, Levenson J, Simon A, Meyer P, Devyrick MA. Platelet cytosolic free proton and free calcium concentrations in essential hypertension. J Hypertens 1989; 7: 485-91.
35. Echeverría RF, Carbajal HA, Salazar MR, Riondet B, Rechifort V, Quaini M. Prevalencia de presión sanguínea normal alta y progresión a hipertensión arterial en una muestra poblacional de La Plata. Medicina (Buenos Aires) 1992; 52: 145-9.
36. Leitschuh M, Cupples LA, Kannel W, Gagnon D, Chobanian A. High-normal blood pressure progression to hypertension in the Framingham Heart Study. Hypertension 1991; 17: 22-7.
37. Blaustein MP. Sodium ions, calcim ions, blood pressure regulation and hypertension: a reassessment and a hypothesis. Am J Physiol 1977; 232: C165-C73.